President Donald Trump will meet on Wednesday with the chief executive officers of eight large retailers.
The group of eight retail bosses will meet on Wednesday with Kevin Brady and with members of the Senate.
Traders may want to think twice before backing out of the reflation trade right now.
The earnings boosts fueled by tax cuts may not be quite as great as everyone had hoped.
The Fed is staying as flexible as possible by maintaining a more dovish tone than the markets expected.
The new terms set shares of Rite Aid at a maximum of $7 per share and $6.50 minimum, down from the initial $9 Walgreens agreed to purchase.
CNBC's Seema Mody reports the latest on the takeover deal between Walgreens and Rite Aid.
Walgreens lowered its acquisition price for the retail pharmacy chain's shares.
The cost that comes with government lies is greater than you think, says Dustin McKissen.
Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns.
The market is a "coiled spring" right now and bank earnings could push stocks past the tipping point.
Is the bank run overdone? Analysts are sounding a note of caution ahead of Q4 earnings.
That leaves 220 workers to focus on Theranos' business plans.
U.S. equities traded mostly lower, as uncertainty over some of Trump's policies gave investors pause, despite solid economic data.
Some of the names on the move ahead of the open.
Leon Cooperman, Omega Advisors chairman & CEO, shares his best stock picks for 2017.
U.S. stock index futures pointed to a lower open on Thursday amid a slew of economic data.
Dow 20,000 could be back in play Thursday as traders watch economic releases on service sector activity and jobs-related data.
U.S. stocks rose on Wednesday as investors digested the Federal Reserve's December meeting minutes.
Stocks rose on Tuesday, the first trading day of 2017, but closed off their session highs as oil prices gave back initial gains.